Atypical Lipomatous Tumors: Should They be Treated Like Other Sarcoma or Not? Surgical Consideration from a Bi-Institutional Experience
Chiara Mussi(University of Modena and Reggio Emilia), Vittorio Quagliuolo(Humanitas University), Rita De Sanctis(Humanitas University), Stefano Bastoni(Istituto Ortopedico Gaetano Pini), Luca Cozzaglio(Fondazione Humanitas per la Ricerca), Fabio Giardina(Orthopedic Institute), Maria S. Bartoli(Orthopedic Institute), Piergiuseppe Colombo(Humanitas University), Antonina Parafioriti(Istituto Ortopedico Gaetano Pini), Matteo Cimino(Humanitas University), Emanuela Morenghi(Humanitas University), Primo Andrea Daolio(Istituto Ortopedico Gaetano Pini)
Cited by 38
Related Papers
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial
|The Lancet Oncology|2017|493
US-Elastography in the Differential Diagnosis of Benign and Malignant Thyroid Nodules
|Thyroid|2008|417
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial
|The Lancet Neurology|2021|260
The nutritional risk in oncology: a study of 1,453 cancer outpatients
|Supportive Care in Cancer|2012|210